Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Black raspberry powder for ulcerative colitis remission
NCT02267694Phase 1Completed
- Sponsor
- UConn Health
- Start
- Aug 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of blackraspberry powder in ulcerative colitis (UC), sponsored by UConn Health. Primary endpoint: Remission rate at 6 months. Started Aug 2013; status: completed.
02
Drugs
blackraspberry powder
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02267694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02267694.